| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |